| Elizabeth C Ahmed, MD | |
|
1450 Chapel St, Priority Testing Center, New Haven, CT 06511-4405 | |
| (203) 789-3628 | |
| (203) 789-3579 |
| Full Name | Elizabeth C Ahmed |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 1450 Chapel St, New Haven, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376551879 | NPI | - | NPPES |
| 001267831 | Medicaid | CT | |
| 2143439 | Other | CT | AETNA |
| 92568497 | Other | CT | OXFORD |
| 010026783CT01 | Other | CA | ANTHEM BLUE SHIELD |
| 026783 | Other | CT | CONNECTICARE |
| 08012145 | Other | CT | RAILROAD MEDICARE |
| 0R0175 | Other | CT | HEALTHNET |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 026783 (Connecticut) | Primary |
| Entity Name | Margaret Chustecka Internal Medicine Of Greater New Haven |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053344473 PECOS PAC ID: 3274557152 Enrollment ID: O20060118000578 |
News Archive
The number of fast food outlets in poor and black neighborhoods may play a role in the obesity epidemic among residents of these areas, suggest the results of a geographical survey.
The spinal tumor grew back. Even though the 16-year old patient endured surgery a year earlier to remove and diagnose the lesion, it was back and its cause unknown. Determined to identify the tumor tissue and set the patient on an appropriate treatment regimen, Albert Telfeian, M.D., a neurosurgeon at Rhode Island Hospital and Hasbro Children's Hospital, performed the first reported case of extracting the tumor endoscopically while the patient was awake and under a local anesthetic.
VION PHARMACEUTICALS, INC. today announced that it had received a complete response letter from the U.S. Food and Drug Administration ("FDA") related to its New Drug Application ("NDA") for Onrigin(TM) (laromustine) injection submitted in February 2009.
Examining 12 major types of cancer, scientists at Washington University School of Medicine in St. Louis have identified 127 repeatedly mutated genes that appear to drive the development and progression of a range of tumors in the body. The discovery sets the stage for devising new diagnostic tools and more personalized cancer treatments.
Although some evidence suggests that statins (the most commonly used type of lipid-lowering drugs) may inhibit tumor development and may work in combination with chemotherapy drugs against cancer, studies on the association between the use of statins and breast cancer have had conflicting results
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth C Ahmed, MD 1450 Chapel St, Priority Testing Center, New Haven, CT 06511-4405 Ph: (203) 789-3628 | Elizabeth C Ahmed, MD 1450 Chapel St, Priority Testing Center, New Haven, CT 06511-4405 Ph: (203) 789-3628 |
News Archive
The number of fast food outlets in poor and black neighborhoods may play a role in the obesity epidemic among residents of these areas, suggest the results of a geographical survey.
The spinal tumor grew back. Even though the 16-year old patient endured surgery a year earlier to remove and diagnose the lesion, it was back and its cause unknown. Determined to identify the tumor tissue and set the patient on an appropriate treatment regimen, Albert Telfeian, M.D., a neurosurgeon at Rhode Island Hospital and Hasbro Children's Hospital, performed the first reported case of extracting the tumor endoscopically while the patient was awake and under a local anesthetic.
VION PHARMACEUTICALS, INC. today announced that it had received a complete response letter from the U.S. Food and Drug Administration ("FDA") related to its New Drug Application ("NDA") for Onrigin(TM) (laromustine) injection submitted in February 2009.
Examining 12 major types of cancer, scientists at Washington University School of Medicine in St. Louis have identified 127 repeatedly mutated genes that appear to drive the development and progression of a range of tumors in the body. The discovery sets the stage for devising new diagnostic tools and more personalized cancer treatments.
Although some evidence suggests that statins (the most commonly used type of lipid-lowering drugs) may inhibit tumor development and may work in combination with chemotherapy drugs against cancer, studies on the association between the use of statins and breast cancer have had conflicting results
› Verified 7 days ago
Joel Daniel Newman Bluman, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 374 Grand Ave, New Haven, CT 06513 Phone: 203-777-7411 Fax: 203-777-8506 | |
Obinna Anosike, Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Long Wharf Dr, New Haven, CT 06511 Phone: 203-781-4444 | |
Rebecca Arnold, PA-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 333 Cedar St, New Haven, CT 06510 Phone: 719-237-9972 | |
Dr. Dorothyann J Van Rhijn, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 55 Lock Street, New Haven, CT 06520 Phone: 203-432-0076 Fax: 203-432-7289 | |
Dr. Kyle Elligers, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 374 Grand Ave, New Haven, CT 06513 Phone: 203-777-7411 Fax: 203-777-8506 | |
Hadrian Holder, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 428 Columbus Avenue, New Haven, CT 06519 Phone: 203-503-3000 Fax: 203-503-3224 | |
Dr. Ashley L Demory, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 |